Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

2.3%

4 terminated/withdrawn out of 171 trials

Success Rate

95.0%

+8.4% vs industry average

Late-Stage Pipeline

11%

18 trials in Phase 3/4

Results Transparency

3%

2 of 76 completed trials have results

Key Signals

33 recruiting2 with results4 withdrawn

Enrollment Performance

Analytics

N/A
82(70.1%)
Phase 2
13(11.1%)
Phase 3
11(9.4%)
Phase 4
7(6.0%)
Phase 1
3(2.6%)
Early Phase 1
1(0.9%)
117Total
N/A(82)
Phase 2(13)
Phase 3(11)
Phase 4(7)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (171)

Showing 20 of 171 trials
NCT06702293Not ApplicableRecruiting

Use of a Digital Psychotherapeutic App to Reduce Symptom Burden in Dermatology Patients

Role: collaborator

NCT07828496Not ApplicableRecruiting

Cognitive Rehabilitation Using Neurofeedback With Brain-computer Interface

Role: lead

NCT06292871Not ApplicableCompleted

The Use of Social Media Platform to Continuously Support Pregnant Women With Gestational Diabetes Mellitus

Role: lead

NCT07534670Not ApplicableRecruiting

Early Pregnancy Lifestyle and Glucose Patterns: A Substudy of TOFFFY

Role: lead

NCT03803345Completed

The Association of Maternal Night-Eating Pattern With Glucose Tolerance During Pregnancy

Role: lead

NCT07773181Not ApplicableNot Yet Recruiting

Nurse Led Aromatherapy

Role: lead

NCT07773259Not ApplicableNot Yet Recruiting

CODEPAD-III (Collaborative Outcomes of DEpression and Pain Associated With Delivery-III)

Role: lead

NCT07768878Not ApplicableCompleted

Enhanced Recovery After Urogynaecological Surgery - Early Urinary Catheter Removal in an Asian Population

Role: lead

NCT05564013Not ApplicableCompleted

Developing a Virtual Reality (VR)-Based Prototype for Perioperative Care - a Proof of Concept Study

Role: collaborator

NCT04014829Recruiting

Evaluation of Central Sensitization, Fear-Avoidance, and Pain-Pressure Threshold With Chronic Pain After Hysterectomy

Role: lead

NCT03231683Phase 2Completed

Use of S+Ketamine During Target-Controlled Intravenous Anaesthesia After Abdominal Hysterectomy

Role: lead

NCT03620942Not ApplicableActive Not Recruiting

Development of Advanced Double Intravenous Vasopressor Automated (ADIVA) System

Role: lead

NCT04011150Phase 3Active Not Recruiting

Development of Variable Volume Automated Mandatory Boluses for Patient-controlled Epidural Analgesia During Labour

Role: lead

NCT04012151Active Not Recruiting

Arm and Finger Measurement for Blood Pressure Surveillance

Role: lead

NCT02543385Not ApplicableWithdrawn

S Ketamine Use in Total Abdominal Hysterectomy

Role: lead

NCT05709327Not ApplicableActive Not Recruiting

Integrating Smart Ring Wearable Technology in Pregnancy Health Monitoring (I-SMART)

Role: lead

NCT06357728Not ApplicableRecruiting

Continuous Glucose Monitoring Glycemic cHAracterization During Pregnancy

Role: lead

NCT07466797Not ApplicableRecruiting

The eHealth Integrated Maternal Physical Activity Programme in Prenatal Care Trial (E-IMPACT)

Role: lead

NCT06929208Not ApplicableRecruiting

Heart Rate Variability and Music Listening

Role: lead

NCT03685422Not ApplicableActive Not Recruiting

Preoperative Virtual Reality to Reduce Pain on Gynaecologic Patients Undergoing Surgery

Role: lead